CD8A and neoplasm: Parallel to the elevation of PD-L1 and MHC-I expression in the tumor tissues after MMC therapy (Fig. 3I, j), the amount of CD3+ and CD8+ infiltrating lymphocytes in the tumor tissues were also found to be significantly increased after MMC therapy (Fig. 3l, m).